Survival after LDLT in recipients ≥70 years old in the United States. An OPTN/UNOS liver transplant registry analysis.

Todd RobinsonPaola Andrea VargasJose OberholzerShawn PelletierNicolas Goldaracena

Published in: Clinical transplantation (2023)

LDLT for recipients aged 70 or greater represents a faster access to transplantation in a safe and feasible manner when compared to similar- aged recipients undergoing DDLT.

Keyphrases

kidney transplantation
cell therapy
mesenchymal stem cells
data analysis